Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 181 AL 195

Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment

García-Alberca JM, Lara JP, Cruz B, Garrido V, Gris E, Barbancho MÁ.

J Nerv Ment Dis. 2013 Mar;201(3):251-7. doi: 10.1097/NMD.0b013e3182848d04.

Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S; REAL.FR Group.

Eur J Clin Pharmacol. 2013 Aug;69(8):1589-97. doi: 10.1007/s00228-013-1506-8. Epub 2013 Apr 16.

Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008

Lazzeroni LC, Halbauer JD, Ashford JW, Noda A, Hernandez B, Azor V, Hozack N, Hasson N, Henderson VW, Yesavage JA, Tinklenberg JR.

J Alzheimers Dis. 2013;36(4):791-8. doi: 10.3233/JAD-130662.

Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study

Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Castot-Villepelet A, Durrieu G, Gras V, Guy C, Jean-Pastor MJ, Jonville-Béra AP, Merlet-Chicoine I, Miremont-Salamé G, Nourhashemi F, Charmes JP; French Centres of Pharmacovigilance Network.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):952-60. doi: 10.1002/pds.3471. Epub 2013 Jun 24.

Molecular links between Alzheimer's disease and diabetes mellitus

Yang Y, Song W.

Neuroscience. 2013 Oct 10;250:140-50. doi: 10.1016/j.neuroscience.2013.07.009. Epub 2013 Jul 16.

Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study

Spalletta G, Gianni W, Giubilei F, Casini AR, Sancesario G, Caltagirone C, Cravello L.

Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):289-91. doi: 10.1097/WAD.0b013e318260ab0a.

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, Nair AK, Siderowf A, Lu M, Arora AK, Agbulos A, Flitter ML, Krautkramer MJ, Sarsour K, Skovronsky DM, Mintun MA; 45-A17 Study Group.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):4-15. doi: 10.1097/WAD.0b013e318279d02a.

Nucleic acid aptamers as novel class of therapeutics to mitigate Alzheimer's disease pathology

Tannenberg RK, Shamaileh HA, Lauridsen LH, Kanwar JR, Dodd PR, Veedu RN.

Curr Alzheimer Res. 2013 May 1;10(4):442-8. doi: 10.2174/1567205011310040009.

Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data

Niva C, Parkinson J, Olsson F, van Schaick E, Lundkvist J, Visser SA.

Eur J Clin Pharmacol. 2013 Jun;69(6):1247-60. doi: 10.1007/s00228-012-1459-3. Epub 2013 Jan 4.

Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine

Boada M, Arranz FJ.

Dement Geriatr Cogn Disord. 2013;35(1-2):23-33. doi: 10.1159/000345989. Epub 2013 Jan 9.

Aripiprazole in the treatment of Alzheimer's disease

De Deyn PP, Drenth AF, Kremer BP, Oude Voshaar RC, Van Dam D.

Expert Opin Pharmacother. 2013 Mar;14(4):459-74. doi: 10.1517/14656566.2013.764989. Epub 2013 Jan 28.

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein J, Haag S, Wietek S, Farlow M, Jessen F.

Lancet Neurol. 2013 Mar;12(3):233-43. doi: 10.1016/S1474-4422(13)70014-0. Epub 2013 Jan 31.

A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease

Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M.

J Alzheimers Dis. 2013;35(2):349-61. doi: 10.3233/JAD-122140.

Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease

Ritchie CW, Zhinchin G.

Int Psychogeriatr. 2013 Apr;25(4):511-5. doi: 10.1017/S1041610212002414.

Diffusion tensor imaging to determine effects of antidementive treatment on cerebral structural connectivity in Alzheimer's disease

Kilimann I, Likitjaroen Y, Hampel H, Teipel S.

Curr Pharm Des. 2013;19(36):6416-25. doi: 10.2174/1381612811319360003.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias